Stock markets have rallied and oil prices fell after U.S. President Donald Trump announced what appears to be a shaky ...

Novo Nordisk drops Hims & Hers because it was selling and promoting a cheaper copycat of Wegovy, its weight loss drug.

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ...

Hims & Hers delivered record Q1 results and expanded into Europe with the Zava acquisition. Click here to see why HIMS stock is a Hold.

U.S. stocks rallied, and the price of oil tumbled Monday on hopes that Iran will not disrupt the global flow of crude, ...

European stock markets surged at Tuesday's open, with investors embracing a significant relief rally fueled by an ...

Novo Nordisk, the company behind blockbuster weight-loss drugs like Ozempic and Wegovy, had a deal with Hims & Hers that ...

Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for patients who have a prescription for the medication but no insurance coverage ...

A person walks in front of an electronic stock board showing Japan's Nikkei index at a securities firm Monday, June 23, 2025, ...

U.S. stocks rallied and the price of oil tumbled Monday in hopes that Iran will not disrupt the global flow of crude, ...